Detalhe da pesquisa
1.
Liquid biopsy-based circulating tumour (ct)DNA analysis of a spectrum of myeloid and lymphoid malignancies yields clinically actionable results.
Histopathology
; 84(7): 1224-1237, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38422618